PI3K Pathway Inhibition
1 clinical trials · Condition
◉ Watch PI3K Pathway Inhibition
| Record | Firm | Date |
|---|---|---|
| A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer (NCT02058381) | Novartis Pharmaceuticals | 2014-05-06 |
Track PI3K Pathway Inhibition automatically
Every clearance here is in the API, with alerts when new ones post.